1. Home
  2. INM vs MTEN Comparison

INM vs MTEN Comparison

Compare INM & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$0.70

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Logo Mingteng International Corporation Inc. Ordinary Shares

MTEN

Mingteng International Corporation Inc. Ordinary Shares

HOLD

Current Price

$1.09

Market Cap

1.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
INM
MTEN
Founded
1981
2015
Country
Canada
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
1.5M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
INM
MTEN
Price
$0.70
$1.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.3K
30.0K
Earning Date
05-12-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,942,633.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.50
N/A
52 Week Low
$0.58
$0.02
52 Week High
$7.98
$26.03

Technical Indicators

Market Signals
Indicator
INM
MTEN
Relative Strength Index (RSI) 44.58 33.86
Support Level $0.58 $0.52
Resistance Level $0.94 $1.35
Average True Range (ATR) 0.05 0.11
MACD 0.01 -0.01
Stochastic Oscillator 38.91 39.61

Price Performance

Historical Comparison
INM
MTEN

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.

Share on Social Networks: